Skip to content

Copper nanoparticles incorporated PRP for wound healing

Copper nanoparticles incorporated plasma rich protein for wound healing - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105841
Enrollment
30
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg

Interventions

Intervention1: Copper nanoparticles incorporated plasma rich protein for wound healing: Copper nanoparticles incorporated plasma rich protein for wound healing in chronic ulcer compared with conventio

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with acute or chronic wounds, including surgical site infections and trauma-related injuries. Individuals with no known allergies to copper-based compounds or plasma-derived products. Wounds classified as mild to moderate in severity, without extensive necrosis or gangrene.

Exclusion criteria

Exclusion criteria: Patients with severe wound infections, extensive necrosis, or gangrene. Individuals with known allergies to copper-based compounds or plasma-derived products. Patients with underlying conditions that may interfere with wound healing, such as uncontrolled diabetes or immunodeficiency disorders.

Design outcomes

Primary

MeasureTime frame
Efficacy of antimicrobial activity of copper nanoparticles,accelerated wound healing,biocompatibility of the productTimepoint: Efficacy of antimicrobial activity of copper nanoparticles,accelerated wound healing,biocompatibility of the product assessed at 4,8 and 12 weeks

Secondary

MeasureTime frame
clinical relevance of the formulation by investigating its safety, cytotoxicity, & effectiveness in promoting tissue regeneration & infection control. Timepoint: Assessed at 12 weeks

Countries

India

Contacts

Public ContactDr varsha S

Saveetha medical College and hospital

rajeshkumars.sdc@saveetha.com96297 39263

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026